Drug reference
Cetrorelix
GnRH Analogue · Infertility treatment
Also known as Cetrorelix acetate
GnRH AnalogueInfertility treatment
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
Avoid in confirmed pregnancy.
FDA category + note
Mechanism
Cetrorelix is a luteinising hormone releasing hormone antagonist. It works by inhibiting the release of gonadotrophins, namely luteinising hormone and follicle stimulating hormone, which are essential for ovulation.
Indications
Adjunct in the treatment of female infertility (initiated under specialist supervision)Infertility by assisted reproductive techniquesSuppression of the LH surge to prevent premature ovulation in ovarian-stimulation protocols as part of assisted reproduction technologyEndometriosis (off-label)Uterine fibroids (off-label)controlled ovarian hyperstimulation (IVF protocols)Inhibiting LH surges during controlled ovarian stimulation in women undergoing in vitro fertilization
Dosing
- Adult
- By subcutaneous injection: 250 micrograms once daily, administered in the morning, starting on day 5 or 6 of ovarian stimulation with gonadotrophins (or each evening starting on day 5 of ovarian stimulation). Continue throughout administration of gonadotrophin including day of ovulation induction (or evening before ovulation induction).…
- Renal adjustment
- Avoid in moderate or severe renal impairment.
- Hepatic adjustment
- Manufacturer advises use with cautionno information available.
Pharmacokinetics
Duration
Once-daily administration suffices for therapeutic effect.
Bioavailability
Exceeds 90% (subcutaneous) within 1 to 2 h
Contraindications
- Confirmed pregnancy
- Moderate or severe renal impairment
- Pregnant women
Side effects
Common
Ovarian hyperstimulation syndromeHeadacheHot flashes (when used alone)Lower risk of ovarian hyperstimulation syndrome compared to agonists
Serious
- Hypersensitivity
- Hypersensitivity reactions, including anaphylaxis
- risk of osteoporosis (with long-term use)
Pregnancy & lactation
Pregnancy
Avoid in confirmed pregnancy.
Lactation
Avoid.
Related guidelines
Abnormal uterine bleeding
FOGSI · Obstetrics & Gynaecology · 2016
Infective endocarditis prevention
NICE · Cardiology / Dentistry · 2008
Infective endocarditis prevention
AHA · Cardiology / Dentistry · 2007
Preoperative cardiac evaluation for non-cardiac surgery
AHA · Cardiology · 2025
Stroke and TIA — secondary prevention
AHA · Neurology · 2021
Other GnRH Analogue drugs
Ask House about Cetrorelix
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-13 · House clinical team